INIS
cancer
100%
patients
74%
tumors
54%
radiotherapy
44%
rectum
32%
notches
27%
doses
24%
esophagus
21%
volume
18%
radiations
18%
hypoxia
15%
diseases
14%
brachytherapy
14%
lung cells
14%
metastases
14%
therapy
13%
proteins
13%
lungs
13%
glioblastomas
13%
comparative evaluations
13%
images
12%
irradiation
12%
combined therapy
11%
inhibition
11%
receptors
11%
positron computed tomography
10%
tissues
10%
serine
10%
glycine
10%
data
9%
reviews
9%
toxicity
9%
nmr imaging
9%
guidelines
9%
validation
9%
synthesis
8%
growth
8%
ligands
8%
drugs
8%
risks
8%
surgery
8%
prediction
8%
stem cells
8%
humans
8%
prostate
8%
apoptosis
7%
levels
7%
values
7%
metabolism
6%
chemotherapy
6%
leukemia
6%
lymph nodes
6%
genes
6%
control
6%
tumor cells
6%
information
6%
in vivo
6%
planning
6%
design
5%
dose rates
5%
learning
5%
quality of life
5%
computed tomography
5%
beams
5%
organs
5%
monitoring
5%
mice
5%
Medicine and Dentistry
Radiation Therapy
40%
Neoplasm
29%
Rectum Cancer
25%
Chemoradiotherapy
23%
Esophageal Cancer
14%
Brachytherapy
14%
Malignant Neoplasm
13%
Glioblastoma
11%
Disease
10%
Non Small Cell Lung Cancer
9%
Overall Survival
8%
Hypoxia
7%
Magnetic Resonance Imaging
7%
Arm
7%
Notch
7%
Lung Cancer
7%
Radiosensitivity
6%
Recurrent Disease
6%
Stem Cell
5%
Positron Emission Tomography-Computed Tomography
5%
Lymph Node
5%
Prostate Cancer
5%
Treatment Response
5%
Keyphrases
Radiotherapy
27%
Colorectal Cancer
20%
Esophageal Cancer
16%
Tumor
13%
Neoadjuvant Chemoradiotherapy (nCRT)
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Chemoradiation
9%
Hypoxia
9%
Cancer Patients
8%
Glioblastoma
8%
Notch Signaling
8%
Glycine
8%
Brachytherapy
7%
Chemoradiotherapy
7%
Radiation Therapy
7%
Lung Cancer
7%
Extracellular Vesicles
7%
In Cancer
7%
Locally Advanced Rectal Cancer
6%
Irradiation
6%
Overall Survival
6%
Tumor Growth
6%
Dose Escalation
6%
Glycine Metabolism
5%
Temozolomide
5%
Autophagy
5%
Notch1
5%
Chemotherapy
5%
Tumor Cells
5%
Clinical Practice
5%
Notch Receptors
5%